1. Home
  2. NPKI vs CRGX Comparison

NPKI vs CRGX Comparison

Compare NPKI & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPKI
  • CRGX
  • Stock Information
  • Founded
  • NPKI 1932
  • CRGX 2021
  • Country
  • NPKI United States
  • CRGX United States
  • Employees
  • NPKI N/A
  • CRGX N/A
  • Industry
  • NPKI Metal Fabrications
  • CRGX
  • Sector
  • NPKI Industrials
  • CRGX
  • Exchange
  • NPKI Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • NPKI 621.1M
  • CRGX 628.6M
  • IPO Year
  • NPKI N/A
  • CRGX 2023
  • Fundamental
  • Price
  • NPKI $7.01
  • CRGX $3.74
  • Analyst Decision
  • NPKI
  • CRGX Hold
  • Analyst Count
  • NPKI 0
  • CRGX 7
  • Target Price
  • NPKI N/A
  • CRGX $4.67
  • AVG Volume (30 Days)
  • NPKI 385.2K
  • CRGX 1.9M
  • Earning Date
  • NPKI 02-19-2025
  • CRGX 03-20-2025
  • Dividend Yield
  • NPKI N/A
  • CRGX N/A
  • EPS Growth
  • NPKI N/A
  • CRGX N/A
  • EPS
  • NPKI N/A
  • CRGX N/A
  • Revenue
  • NPKI $748,372,000.00
  • CRGX N/A
  • Revenue This Year
  • NPKI N/A
  • CRGX N/A
  • Revenue Next Year
  • NPKI N/A
  • CRGX N/A
  • P/E Ratio
  • NPKI N/A
  • CRGX N/A
  • Revenue Growth
  • NPKI 93.70
  • CRGX N/A
  • 52 Week Low
  • NPKI $5.61
  • CRGX $3.00
  • 52 Week High
  • NPKI $8.65
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • NPKI N/A
  • CRGX 20.88
  • Support Level
  • NPKI N/A
  • CRGX $3.00
  • Resistance Level
  • NPKI N/A
  • CRGX $3.88
  • Average True Range (ATR)
  • NPKI 0.00
  • CRGX 0.92
  • MACD
  • NPKI 0.00
  • CRGX -1.00
  • Stochastic Oscillator
  • NPKI 0.00
  • CRGX 5.99

About NPKI NPK International Inc. Common Stock

NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: